Hizentra 1 Vial 1 g/5 ml

Hizentra 1 Vial 1 g/5 ml

See More by CSL Behring

Format:

1 Vial — 1 g/5 ml

Use for:

Hizentra is an immunoglobulin replacement therapy used to treat primary immunodeficiency disorders. It helps replace important antibodies that the body is not able to make on its own.

Note:

Turkish packaging

Active ingredient: Immune globulin Subcutaneous

Price:

$200

Hizentra is an intravenous (IV) immune globulin therapy used to treat primary immunodeficiency diseases (PIDD). It contains high levels of antibodies used to help fight infections and other diseases caused by PIDD. Hizentra is the first and only subcutaneous immune globulin approved by the FDA for use in adults and children. It is administered once a week, or more often if required, and is designed to provide a more convenient and consistent dosing regimen than other IV immunoglobulin treatments. Hizentra can help to improve quality of life by providing patients with reliable, predictable protection against infection and more opportunities to participate in everyday activities. It is also associated with a lower risk of infection compared to other IV immunoglobulin treatments.

Hizentra is administered through a simple subcutaneous injection, which requires no special training and can be done in the comfort of the patient's home. Hizentra is safe and effective, and can be used in combination with other treatments for PIDD.